About
Deep Origin is a comprehensive AI-powered platform transforming small molecule drug discovery by making cutting-edge computational chemistry accessible to scientists at every skill level. It integrates physics-driven molecular simulations with AI-accelerated machine learning, enabling research teams to identify promising drug candidates significantly faster and at lower cost. The platform's three flagship tools serve distinct workflows. Balto AI is a no-code conversational assistant allowing researchers to search databases like PDB, ChEMBL, UniProt, PubChem, and patents, predict ADMET properties and drug-likeness, perform high-accuracy ligand docking, and visualize molecules in 2D/3D—all using plain English with no computational expertise required. The Deep Origin API offers full programmatic control for developers, supporting protein preparation, binding pocket detection, ABFE/RBFE free energy simulations, and processing millions of molecules at enterprise scale. DO Patent automatically converts PDFs of patents and scientific literature into accurate, editable molecular structures with over 98% accuracy—100x faster than manual redrawing and 12x faster than competing tools. Backed by a world-class team of computational scientists, medicinal chemists, physicists, and biologists, Deep Origin has received a $31.7M ARPA-H government contract to develop in-silico alternatives to animal testing. The platform is SOC-2 compliant with end-to-end encryption, making it suitable for academic researchers and large pharmaceutical enterprises alike.
Key Features
- Balto AI – No-Code Drug Discovery Assistant: A conversational AI assistant for chemistry, docking, and drug discovery. Search PDB, ChEMBL, UniProt, PubChem, and patent databases, predict ADMET properties, and perform high-accuracy ligand docking using plain English—no coding required.
- Deep Origin API – Programmatic Molecular Workflows: Full code-first access to drug discovery capabilities including protein preparation, binding pocket detection, ABFE/RBFE free energy simulations, and the ability to process millions of molecules at enterprise scale.
- DO Patent – Molecular Structure Extraction: Automatically converts scientific papers and patent PDFs into accurate, editable molecular structures with over 98% accuracy—100x faster than manual redrawing and 12x faster than competing tools.
- Physics-Driven Molecular Simulations: Simulations grounded in molecular physics rather than pure pattern matching, delivering trustworthy, high-accuracy results even for novel drug targets outside existing training literature.
- Enterprise-Scale Secure Infrastructure: SOC-2 compliant, end-to-end encrypted cloud infrastructure designed to scale with large pharmaceutical and biotech pipelines processing millions of molecules.
Use Cases
- Screening millions of small molecule candidates for binding affinity against a protein target using the Deep Origin API's docking and free energy simulation capabilities.
- Enabling medicinal chemists without computational backgrounds to run ligand docking and predict ADMET properties through Balto AI's conversational interface.
- Digitizing and analyzing molecular structures from competitor patents or published literature at scale using DO Patent to accelerate IP research and competitive intelligence.
- Running ABFE/RBFE free energy perturbation simulations to rank and prioritize drug candidates before committing resources to synthesis and wet-lab testing.
- Building custom, scalable drug discovery pipelines for biotech startups or CROs that require cloud-based molecular simulation infrastructure without in-house DevOps.
Pros
- Accessible to Non-Computational Scientists: Balto AI's plain-English interface eliminates the need for computational expertise, enabling medicinal chemists and biologists to run advanced simulations without specialized training.
- Dramatically Faster Research Timelines: Workflows that previously took weeks now take hours. DO Patent is 100x faster than manual structure redrawing, and the platform as a whole accelerates the entire discovery pipeline.
- Flexible for Developers and Researchers: Offers both a no-code AI assistant and a fully programmatic API, catering to a wide range of technical backgrounds and workflow requirements within the same organization.
- Scientifically Credible and Government-Validated: Backed by peer-reviewed research and a $31.7M ARPA-H contract, Deep Origin has demonstrated scientific rigor and earned regulatory confidence.
Cons
- Highly Specialized Use Case: Deep Origin is built exclusively for drug discovery and computational chemistry, making it unsuitable for general scientific research or other industries.
- API Access Requires Application: Full programmatic access via the Deep Origin API is gated behind a request process, which may slow onboarding for developers seeking immediate integration.
- Advanced Features Still Require Domain Knowledge: While Balto AI simplifies many workflows, getting the most from ABFE/RBFE free energy simulations and advanced docking configurations still demands significant chemistry expertise.
Frequently Asked Questions
What is Deep Origin?
Deep Origin is an AI-powered drug discovery platform that combines physics-based molecular simulations with machine learning to help scientists identify and develop small molecule drug candidates faster and more affordably than traditional methods.
Is Deep Origin free to use?
Deep Origin offers free tiers for both Balto AI and DO Patent. The Deep Origin API for large-scale, programmatic molecular workflows requires requesting access and may involve paid or enterprise pricing plans.
What is Balto AI?
Balto AI is Deep Origin's no-code conversational drug discovery assistant. Users can search molecular databases (PDB, ChEMBL, UniProt, PubChem, patents), predict ADMET properties, perform ligand docking, and visualize molecules in 2D/3D simply by asking questions in plain English.
What is DO Patent and how accurate is it?
DO Patent is a tool that automatically extracts molecular structures from scientific papers and patents in PDF format, converting them into accurate, editable structures with over 98% accuracy. It is 100x faster than manual redrawing and 12x faster than competing extraction tools.
Who is Deep Origin designed for?
Deep Origin is designed for drug discovery scientists, medicinal chemists, computational biologists, and pharmaceutical or biotech organizations of all sizes—from academic research labs to large enterprise teams running high-throughput screening pipelines.
